Please login to the form below

Not currently logged in
Email:
Password:

Cadence Pharma

This page shows the latest Cadence Pharma news and features for those working in and with pharma, biotech and healthcare.

Mallinckrodt pays $1.2bn for Sucampo Pharma

Mallinckrodt pays $1.2bn for Sucampo Pharma

As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug Amitizia - for $1.2bn. ... bought Cadence Pharma for $1.3bn, Questcor for $6.5bn, immunotherapy outfit Therakos for $1.3bn and nuclear

Latest news

  • Ireland's Mallinckrodt buys US regenerative medicine firm Ireland's Mallinckrodt buys US regenerative medicine firm

    Stratatech’s StrataGraft in phase III testing for burns treatment. Ireland's Mallinckrodt Pharma has continued its acquisitive streak with a deal to buy Stratatech, a US firm developing a biologic ... Cadence Pharma and its injectable painkiller

  • Mallinckrodt cuts $5.6bn deal to buy Questcor Mallinckrodt cuts $5.6bn deal to buy Questcor

    Irish company continues move from medical imaging to pharma products. Mallinckrodt has dug deep into its pockets to buy Questcor Pharma and gain ownership of its fast-growing specialty drug HP ... It is the second transaction for Mallinckrodt in as many

  • Mallinckrodt offers $1.3bn for Cadence Pharma

    Deal would include injectable painkiller Ofirmev. Irish pharma company Mallinckrodt has agreed a $1.3bn deal to buy US biotech Cadence Pharmaceuticals and its fast-growing injectable painkiller Ofirmev. ... Mallinckrodt's offer comes shortly after

  • Cadence IV pain drug approved

    Cadence Pharmaceuticals has won US FDA approval for Ofirmev,  the first intravenous formulation of acetaminophen to be marketed in the US. ... Cadence Pharmaceuticals has won US Food and Drug Administration (FDA) approval for Ofirmev, which will become

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics